Search results
Results from the WOW.Com Content Network
If you’ve been diagnosed with chronic lymphocytic leukemia, your cancer care team will discuss your treatment options with you. It’s important that you think carefully about each of your choices. Weigh the benefits of each treatment option against the possible risks and side effects.
Chronic lymphocytic leukemia (CLL) treatment options can include observation, steroids, chemotherapy, targeted therapy, and/or stem cell transplant. Get detailed information about newly diagnosed and recurrent CLL and available treatment modalities in this summary for clinicians.
Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more about the diagnosis, prognosis, and treatment of newly diagnosed or recurrent CLL in this expert-reviewed summary.
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Your treatment options for chronic lymphocytic leukemia depend on several factors, such as the stage of your cancer, whether you're experiencing signs and symptoms, your overall health, and your preferences.
Abstract. SUMMARY – Recent developments in the diagnosis and treatment of chronic lymphocytic leukemia (B-CLL) have led to change of approach in clinical practice.
Health Professional Version. PDQ Adult Treatment Editorial Board. Published online: October 4, 2024. This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of chronic lymphocytic leukemia.
The following ESMO Clinical Practice Guideline (CPG) has been recently updated with new treatment recommendations and updated algorithms for managing early and advanced disease: Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 1.
Recommendation. Routine screening for CLL is not recommended either in the general population or in relatives of patients with CLL [V, E]. DIAGNOSIS AND PATHOLOGY/MOLECULAR BIOLOGY. The diagnosis of CLL is established by the following criteria:1,2.
Article Info. Download PDF. Outline. Share. More. incidence. Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world with an incidence of 4.2/100 000/year [1]. The incidence increases to >30/100 000/year at an age of >80 years. The median age at diagnosis is 72 years.